StonvexLoading…
StonvexStonvexStonvexCore line items from ENPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $282.90M | $1.47B | $1.13B | $719.24M |
Operating Income | $-29.64M | $157.53M | $135.09M | $68.93M |
Net Income | $-7.41M | $172.13M | $133.42M | $66.78M |
EPS (Diluted) | $-0.06 | $1.29 | $1.01 | $0.50 |
Total Assets | $2.72B | $3.51B | $3.32B | $3.18B |
Total Liabilities | $1.62B | $2.42B | $2.33B | $2.30B |
Cash & Equivalents | $497.55M | $474.32M | $401.88M | $370.54M |
Free Cash Flow OCF − CapEx | $82.97M | $95.90M | $58.06M | $52.18M |
Shares Outstanding | 131.78M | 131.08M | 130.85M | 130.74M |